DRUG · Mapped RxNorm record
Liraglutide
Normalized identity: liraglutideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
NCT02655770
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetes Mellitus Type 2unresolved
Diastolic Dysfunctionunresolved
Cardiac MRIunresolved
Myocardial Perfusionunresolved
Interventions
LiraglutideDRUG · verified · RxNorm: liraglutide
PlaceboDRUG
Sponsors & collaborators
Copenhagen University Hospital, Rigshospitaletlead sponsor
Slagelse Hospitalcollaborator
Novo Nordisk A/Scollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02655770 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.